Presentation
5 March 2021 Pancreatic islet characterisation by the hyperspectral Assessment of autofluorescence: a non-invasive, label-free measure of viability
Author Affiliations +
Abstract
Type 1 diabetes occurs when insulin secreting beta cells in pancreatic islets are destroyed leading to elevated glucose and ill health. Islet transplantation is an effective therapy, but islets are often damaged by the isolation process resulting in numerous, repeated transplants to achieve insulin independence. We have applied hyperspectral microscopy to damaged islets and have shown through the assessment of native cell autofluorescence we can detect heterogenous forms of damage (elevated ROS, inflammatory signalling and warm ischemia) in mouse islets. This approach has great potential to be translated clinically to minimise the burden of suboptimal islet transplantations.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jared M. Campbell, Stacey N. Walters, Saabah B. Mahbub, Abbas Habibalahi, Ayad G. Anwer, Shane T. Grey, and Ewa M. Goldys "Pancreatic islet characterisation by the hyperspectral Assessment of autofluorescence: a non-invasive, label-free measure of viability", Proc. SPIE 11655, Label-free Biomedical Imaging and Sensing (LBIS) 2021, 1165506 (5 March 2021); https://doi.org/10.1117/12.2578220
Advertisement
Advertisement
KEYWORDS
Ischemia

Transplantation

Blood

Glucose

Hyperspectral imaging

Inflammation

Microscopy

Back to Top